The VMAT-2 inhibitor tetrabenazine alters effort-related decision making as measured by the T-maze barrier choice task: reversal with the adenosine A2A antagonist MSX-3 and the catecholamine uptake blocker bupropion (Q48190081)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	The VMAT-2 inhibitor tetrabenazine alters effort-related decision making as measured by the T-maze barrier choice task: reversal with the adenosine A2A antagonist MSX-3 and the catecholamine uptake blocker bupropion	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/25323625

The VMAT-2 inhibitor tetrabenazine alters effort-related decision making as measured by the T-maze barrier choice task: reversal with the adenosine A2A antagonist MSX-3 and the catecholamine uptake blocker bupropion (English)

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/25323625

decision making

1 reference

based on heuristic

inferred from title

Christa E Müller

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25323625%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25323625%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

John D. Salamone

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25323625%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25323625%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

author name string

Samantha E Yohn

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25323625%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

Christian Thompson

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25323625%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

Patrick A Randall

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25323625%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

Christie A Lee

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25323625%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

publication date

17 October 2014

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/25323625

Psychopharmacology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25323625%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

232

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25323625%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25323625%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

1313-1323

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25323625%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

Anhedonia revisited: is there a role for dopamine-targeting drugs for depression?

1 reference

https://api.crossref.org/works/10.1007%2FS00213-014-3766-0

21 January 2018

Dopamine modulates effort-based decision making in rats

1 reference

https://api.crossref.org/works/10.1007%2FS00213-014-3766-0

21 January 2018

Clinical presentation and outcome of geriatric depression in subcortical ischemic vascular disease

1 reference

https://api.crossref.org/works/10.1007%2FS00213-014-3766-0

21 January 2018

A proposal of decision tree to screen putative antidepressants using forced swim and tail suspension tests

1 reference

https://api.crossref.org/works/10.1007%2FS00213-014-3766-0

21 January 2018

Mice with chronically elevated dopamine exhibit enhanced motivation, but not learning, for a food reward

1 reference

https://api.crossref.org/works/10.1007%2FS00213-014-3766-0

21 January 2018

Motor and cognitive aspects of motor retardation in depression

1 reference

https://api.crossref.org/works/10.1007%2FS00213-014-3766-0

21 January 2018

A quantitative neuromotor predictor of antidepressant non-response in patients with major depression

1 reference

https://api.crossref.org/works/10.1007%2FS00213-014-3766-0

21 January 2018

Tetrabenazine for the treatment of hyperkinetic movement disorders: a review of the literature.

1 reference

https://api.crossref.org/works/10.1007%2FS00213-014-3766-0

21 January 2018

Resolution of sleepiness and fatigue: a comparison of bupropion and selective serotonin reuptake inhibitors in subjects with major depressive disorder achieving remission at doses approved in the European Union

1 reference

https://api.crossref.org/works/10.1007%2FS00213-014-3766-0

21 January 2018

Different effects of nucleus accumbens and ventrolateral striatal dopamine depletions on instrumental response selection in the rat.

1 reference

https://api.crossref.org/works/10.1007%2FS00213-014-3766-0

21 January 2018

Nucleus accumbens dopamine depletions alter relative response allocation in a T-maze cost/benefit task.

1 reference

https://api.crossref.org/works/10.1007%2FS00213-014-3766-0

21 January 2018

Effort-based cost-benefit valuation and the human brain

1 reference

https://api.crossref.org/works/10.1007%2FS00213-014-3766-0

21 January 2018

Norepinephrine-deficient mice lack responses to antidepressant drugs, including selective serotonin reuptake inhibitors

1 reference

https://api.crossref.org/works/10.1007%2FS00213-014-3766-0

21 January 2018

The many faces of fatigue in major depressive disorder

1 reference

https://api.crossref.org/works/10.1007%2FS00213-014-3766-0

21 January 2018

Differential involvement of serotonin and dopamine systems in cost-benefit decisions about delay or effort.

1 reference

https://api.crossref.org/works/10.1007%2FS00213-014-3766-0

21 January 2018

Adenosine A(2A) receptor antagonism reverses the effects of dopamine receptor antagonism on instrumental output and effort-related choice in the rat: implications for studies of psychomotor slowing

1 reference

https://api.crossref.org/works/10.1007%2FS00213-014-3766-0

21 January 2018

Forebrain circuitry involved in effort-related choice: Injections of the GABAA agonist muscimol into ventral pallidum alter response allocation in food-seeking behavior

1 reference

https://api.crossref.org/works/10.1007%2FS00213-014-3766-0

21 January 2018

Nucleus accumbens and effort-related functions: behavioral and neural markers of the interactions between adenosine A2A and dopamine D2 receptors.

1 reference

https://api.crossref.org/works/10.1007%2FS00213-014-3766-0

21 January 2018

An update on adenosine A2A-dopamine D2 receptor interactions: implications for the function of G protein-coupled receptors

1 reference

https://api.crossref.org/works/10.1007%2FS00213-014-3766-0

21 January 2018

Amygdala-prefrontal cortical circuitry regulates effort-based decision making

1 reference

https://api.crossref.org/works/10.1007%2FS00213-014-3766-0

21 January 2018

Dopaminergic and glutamatergic regulation of effort- and delay-based decision making

1 reference

https://api.crossref.org/works/10.1007%2FS00213-014-3766-0

21 January 2018

Intra-accumbens injections of the adenosine A2A agonist CGS 21680 affect effort-related choice behavior in rats

1 reference

https://api.crossref.org/works/10.1007%2FS00213-014-3766-0

21 January 2018

Tetrabenazine as anti-chorea therapy in Huntington disease: an open-label continuation study. Huntington Study Group/TETRA-HD Investigators

1 reference

https://api.crossref.org/works/10.1007%2FS00213-014-3766-0

21 January 2018

Tetrabenazine: the first approved drug for the treatment of chorea in US patients with Huntington disease.

1 reference

https://api.crossref.org/works/10.1007%2FS00213-014-3766-0

21 January 2018

Differential effects on effort discounting induced by inactivations of the nucleus accumbens core or shell

1 reference

https://api.crossref.org/works/10.1007%2FS00213-014-3766-0

21 January 2018

Negative symptoms of schizophrenia are associated with abnormal effort-cost computations

1 reference

https://api.crossref.org/works/10.1007%2FS00213-014-3766-0

21 January 2018

Tetrabenazine, a monoamine-depleting drug used in the treatment of hyperkinetic movement disorders

1 reference

https://api.crossref.org/works/10.1007%2FS00213-014-3766-0

21 January 2018

Prefrontostriatal circuitry regulates effort-related decision making

1 reference

https://api.crossref.org/works/10.1007%2FS00213-014-3766-0

21 January 2018

Multigram-scale syntheses, stability, and photoreactions of A2A adenosine receptor antagonists with 8-styrylxanthine structure: potential drugs for Parkinson's disease

1 reference

https://api.crossref.org/works/10.1007%2FS00213-014-3766-0

21 January 2018

Characterization of the Potent and Highly Selective A(2A) Receptor Antagonists Preladenant and SCH 412348 [7-[2-[4-2,4-Difluorophenyl]-1-piperazinyl]ethyl]-2-(2-furanyl)-7H-pyraz olo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidin-5-amine] in Rodent Models of

1 reference

https://api.crossref.org/works/10.1007%2FS00213-014-3766-0

21 January 2018

Venlafaxine enhances the effect of bupropion on extracellular dopamine in rat frontal cortex

1 reference

https://api.crossref.org/works/10.1007%2FS00213-014-3766-0

21 January 2018

Amitriptyline normalizes tetrabenazine-induced changes in cerebral microcirculation

1 reference

https://api.crossref.org/works/10.1007%2FS00213-014-3766-0

21 January 2018

Effects of bupropion on the forced swim test and release of dopamine in the nucleus accumbens in ACTH-treated rats

1 reference

https://api.crossref.org/works/10.1007%2FS00213-014-3766-0

21 January 2018

Role of muscles accumbens dopamine D1 and D2 receptors in instrumental and Pavlovian paradigms of conditioned reward

1 reference

https://api.crossref.org/works/10.1007%2FS00213-014-3766-0

21 January 2018

Choosing to make an effort: the role of striatum in signaling physical effort of a chosen action

1 reference

https://api.crossref.org/works/10.1007%2FS00213-014-3766-0

21 January 2018

In vivo activity of bupropion at the human dopamine transporter as measured by positron emission tomography

1 reference

https://api.crossref.org/works/10.1007%2FS00213-014-3766-0

21 January 2018

Coffee, caffeine, and risk of depression among women

1 reference

https://api.crossref.org/works/10.1007%2FS00213-014-3766-0

21 January 2018

Motivational states influence effort-based decision making in rats: the role of dopamine in the nucleus accumbens

1 reference

https://api.crossref.org/works/10.1007%2FS00213-014-3766-0

21 January 2018

Measuring reinforcement learning and motivation constructs in experimental animals: relevance to the negative symptoms of schizophrenia

1 reference

https://api.crossref.org/works/10.1007%2FS00213-014-3766-0

21 January 2018

Invigoration of reward seeking by cue and proximity encoding in the nucleus accumbens

1 reference

https://api.crossref.org/works/10.1007%2FS00213-014-3766-0

21 January 2018

Nucleus accumbens adenosine A2A receptors regulate exertion of effort by acting on the ventral striatopallidal pathway

1 reference

https://api.crossref.org/works/10.1007%2FS00213-014-3766-0

21 January 2018

The adenosine A2A antagonist MSX-3 reverses the effects of the dopamine antagonist haloperidol on effort-related decision making in a T-maze cost/benefit procedure

1 reference

https://api.crossref.org/works/10.1007%2FS00213-014-3766-0

21 January 2018

The flexible approach hypothesis: unification of effort and cue-responding hypotheses for the role of nucleus accumbens dopamine in the activation of reward-seeking behavior

1 reference

https://api.crossref.org/works/10.1007%2FS00213-014-3766-0

21 January 2018

D1 or D2 antagonism in nucleus accumbens core or dorsomedial shell suppresses lever pressing for food but leads to compensatory increases in chow consumption

1 reference

https://api.crossref.org/works/10.1007%2FS00213-014-3766-0

21 January 2018

Differential effects of selective adenosine antagonists on the effort-related impairments induced by dopamine D1 and D2 antagonism

1 reference

https://api.crossref.org/works/10.1007%2FS00213-014-3766-0

21 January 2018

Nucleus accumbens neurotransmission and effort-related choice behavior in food motivation: effects of drugs acting on dopamine, adenosine, and muscarinic acetylcholine receptors.

1 reference

https://api.crossref.org/works/10.1007%2FS00213-014-3766-0

21 January 2018

Effort-related motivational effects of the VMAT-2 inhibitor tetrabenazine: implications for animal models of the motivational symptoms of depression.

1 reference

https://api.crossref.org/works/10.1007%2FS00213-014-3766-0

21 January 2018

Effort-related motivational effects of the pro-inflammatory cytokine interleukin 1-beta: studies with the concurrent fixed ratio 5/ chow feeding choice task

1 reference

https://api.crossref.org/works/10.1007%2FS00213-014-3766-0

21 January 2018

Fatigue as a core symptom in major depressive disorder: overview and the role of bupropion

1 reference

https://api.crossref.org/works/10.1007%2FS00213-014-3766-0

21 January 2018

Resolution of sleepiness and fatigue in major depressive disorder: A comparison of bupropion and the selective serotonin reuptake inhibitors

1 reference

https://api.crossref.org/works/10.1007%2FS00213-014-3766-0

21 January 2018

Adenosine A2A receptor antagonism and genetic deletion attenuate the effects of dopamine D2 antagonism on effort-based decision making in mice.

1 reference

https://api.crossref.org/works/10.1007%2FS00213-014-3766-0

21 January 2018

Tetrabenazine-induced depletion of brain monoamines: characterization and interaction with selected antidepressants

1 reference

https://api.crossref.org/works/10.1007%2FS00213-014-3766-0

21 January 2018

The vesicular monoamine transporter (VMAT-2) inhibitor tetrabenazine induces tremulous jaw movements in rodents: implications for pharmacological models of parkinsonian tremor.

1 reference

https://api.crossref.org/works/10.1007%2FS00213-014-3766-0

21 January 2018

Dopaminergic hypothesis for retarded depression: a symptom profile for predicting therapeutical responses

1 reference

https://api.crossref.org/works/10.1007%2FS00213-014-3766-0

21 January 2018

Dopaminergic modulation of effort-related choice behavior as assessed by a progressive ratio chow feeding choice task: pharmacological studies and the role of individual differences

1 reference

https://api.crossref.org/works/10.1007%2FS00213-014-3766-0

21 January 2018

The VMAT-2 inhibitor tetrabenazine affects effort-related decision making in a progressive ratio/chow feeding choice task: reversal with antidepressant drugs.

1 reference

https://api.crossref.org/works/10.1007%2FS00213-014-3766-0

21 January 2018

A role for mesencephalic dopamine in activation: commentary on Berridge (2006).

1 reference

https://api.crossref.org/works/10.1007%2FS00213-014-3766-0

21 January 2018

Parkinsonian motor characteristics in unipolar major depression.

1 reference

https://api.crossref.org/works/10.1007%2FS00213-014-3766-0

21 January 2018

Motivational views of reinforcement: implications for understanding the behavioral functions of nucleus accumbens dopamine.

1 reference

https://api.crossref.org/works/10.1007%2FS00213-014-3766-0

21 January 2018

The mysterious motivational functions of mesolimbic dopamine.

1 reference

https://api.crossref.org/works/10.1007%2FS00213-014-3766-0

21 January 2018

Haloperidol and nucleus accumbens dopamine depletion suppress lever pressing for food but increase free food consumption in a novel food choice procedure

1 reference

https://api.crossref.org/works/10.1007%2FS00213-014-3766-0

21 January 2018

Anhedonia or anergia? Effects of haloperidol and nucleus accumbens dopamine depletion on instrumental response selection in a T-maze cost/benefit procedure.

1 reference

https://api.crossref.org/works/10.1007%2FS00213-014-3766-0

21 January 2018

Behavioral functions of nucleus accumbens dopamine: empirical and conceptual problems with the anhedonia hypothesis

1 reference

https://api.crossref.org/works/10.1007%2FS00213-014-3766-0

21 January 2018

Dopamine antagonists alter response allocation but do not suppress appetite for food in rats: contrast between the effects of SKF 83566, raclopride, and fenfluramine on a concurrent choice task

1 reference

https://api.crossref.org/works/10.1007%2FS00213-014-3766-0

21 January 2018

Effort-related functions of nucleus accumbens dopamine and associated forebrain circuits

1 reference

https://api.crossref.org/works/10.1007%2FS00213-014-3766-0

21 January 2018

Differential actions of adenosine A1 and A2A antagonists on the effort-related effects of dopamine D2 antagonism

1 reference

https://api.crossref.org/works/10.1007%2FS00213-014-3766-0

21 January 2018

The novel adenosine A(2A) antagonist prodrug MSX-4 is effective in animal models related to motivational and motor functions

1 reference

https://api.crossref.org/works/10.1007%2FS00213-014-3766-0

21 January 2018

Involvement of the rat anterior cingulate cortex in control of instrumental responses guided by reward expectancy

1 reference

https://api.crossref.org/works/10.1007%2FS00213-014-3766-0

21 January 2018

Acute stress induces selective alterations in cost/benefit decision-making

1 reference

https://api.crossref.org/works/10.1007%2FS00213-014-3766-0

21 January 2018

Withdrawal syndrome after the double-blind cessation of caffeine consumption

1 reference

https://api.crossref.org/works/10.1007%2FS00213-014-3766-0

21 January 2018

The dopamine reuptake inhibitor MRZ-9547 increases progressive ratio responding in rats

1 reference

https://api.crossref.org/works/10.1007%2FS00213-014-3766-0

21 January 2018

Distribution, biochemistry and function of striatal adenosine A2A receptors

1 reference

https://api.crossref.org/works/10.1007%2FS00213-014-3766-0

21 January 2018

TJS-010, a new prescription of oriental medicine, antagonizes tetrabenazine-induced suppression of spontaneous locomotor activity in rats

1 reference

https://api.crossref.org/works/10.1007%2FS00213-014-3766-0

21 January 2018

Longitudinal changes of day-time and night-time gross motor activity in clinical responders and non-responders of major depression

1 reference

https://api.crossref.org/works/10.1007%2FS00213-014-3766-0

21 January 2018

Reconsidering anhedonia in depression: lessons from translational neuroscience

1 reference

https://api.crossref.org/works/10.1007%2FS00213-014-3766-0

21 January 2018

Effort-based decision-making in major depressive disorder: a translational model of motivational anhedonia

1 reference

https://api.crossref.org/works/10.1007%2FS00213-014-3766-0

21 January 2018

Increasing dopamine D2 receptor expression in the adult nucleus accumbens enhances motivation

1 reference

https://api.crossref.org/works/10.1007%2FS00213-014-3766-0

21 January 2018

Tetrabenazine is neuroprotective in Huntington's disease mice

1 reference

https://api.crossref.org/works/10.1007%2FS00213-014-3766-0

21 January 2018

Amping up effort: effects of d-amphetamine on human effort-based decision-making

1 reference

https://api.crossref.org/works/10.1007%2FS00213-014-3766-0

21 January 2018

Negative symptoms: A review of schizophrenia, melancholic depression and Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1007%2FS00213-014-3766-0

21 January 2018

The adenosine A2A antagonist MSX-3 reverses the effort-related effects of dopamine blockade: differential interaction with D1 and D2 family antagonists

1 reference

https://api.crossref.org/works/10.1007%2FS00213-014-3766-0

21 January 2018

Antidepressant-like activity of the adenosine A(2A) receptor antagonist, istradefylline (KW-6002), in the forced swim test and the tail suspension test in rodents

1 reference

https://api.crossref.org/works/10.1007%2FS00213-014-3766-0

21 January 2018

Antidepressant activity of the adenosine A2A receptor antagonist, istradefylline (KW-6002) on learned helplessness in rats

1 reference

https://pubmed.ncbi.nlm.nih.gov/25323625

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antidepressant monotherapy: A claims database analysis of treatment changes and treatment duration

1 reference

https://pubmed.ncbi.nlm.nih.gov/25323625

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bupropion increases selection of high effort activity in rats tested on a progressive ratio/chow feeding choice procedure: implications for treatment of effort-related motivational symptoms

1 reference

https://pubmed.ncbi.nlm.nih.gov/25323625

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunohistochemical localization of adenosine A2A receptors in the rat central nervous system

1 reference

https://pubmed.ncbi.nlm.nih.gov/25323625

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Biochemical and anatomical substrates of depression and sickness behavior

1 reference

https://pubmed.ncbi.nlm.nih.gov/25323625

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The psychopharmacology of energy and fatigue.

1 reference

https://pubmed.ncbi.nlm.nih.gov/25323625

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Toward the future of psychiatric diagnosis: the seven pillars of RDoC

1 reference

https://pubmed.ncbi.nlm.nih.gov/25323625

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Toward a generalizable model of symptoms in major depressive disorder

1 reference

https://pubmed.ncbi.nlm.nih.gov/25323625

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Functional specialization within medial frontal cortex of the anterior cingulate for evaluating effort-related decisions.

1 reference

https://pubmed.ncbi.nlm.nih.gov/25323625

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cerebromicrocirculatory defects in animal model of depression

1 reference

https://pubmed.ncbi.nlm.nih.gov/25323625

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A multicenter evaluation of bupropion versus placebo in hospitalized depressed patients.

1 reference

https://pubmed.ncbi.nlm.nih.gov/25323625

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical relevance of fatigue as a residual symptom in major depressive disorder

1 reference

https://pubmed.ncbi.nlm.nih.gov/25323625

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Incentive salience: novel treatment strategies for major depression

1 reference

https://pubmed.ncbi.nlm.nih.gov/25323625

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

DEPRES II (Depression Research in European Society II): a patient survey of the symptoms, disability and current management of depression in the community. DEPRES Steering Committee

1 reference

https://pubmed.ncbi.nlm.nih.gov/25323625

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48190081&oldid=2209199495"